Just announced this morning, does anyone have any other input on this?

 

Kind regards, R

 

    NOVARTIS <NOVN.VX>
    Two popular leukemia drugs, Gleevec and Sutent, kept lab mice from
developing type 1 diabetes and put 80 percent of diabetic mice in remission, an
international team said.
    Both drugs -- Gleevec, or imatinib, made by Novartis AG <NOVN.VX> and
Sutent, or sunitinib, made by Pfizer Inc <PFE.N> -- worked by depressing the
immune systems in the mice, which maintained normal blood sugar levels even
after treatment ended.